173 related articles for article (PubMed ID: 30338914)
21. MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1.
Wang Y; Zhu K; Yu W; Wang H; Liu L; Wu Q; Li S; Guo J
Biochem Biophys Res Commun; 2017 Nov; 493(1):227-232. PubMed ID: 28899784
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor binding protein 7 accelerates hepatic steatosis and insulin resistance in non-alcoholic fatty liver disease.
Yan H; Li T; Wang Y; Li H; Xu J; Lu X
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1101-1110. PubMed ID: 31397492
[TBL] [Abstract][Full Text] [Related]
23. miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes.
Wang JJ; Zhang YT; Tseng YJ; Zhang J
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):360-365. PubMed ID: 31126802
[TBL] [Abstract][Full Text] [Related]
24. Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2.
Kim JH; Jung DY; Nagappan A; Jung MH
Sci Rep; 2018 Sep; 8(1):13734. PubMed ID: 30214048
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR.
Nie H; Song C; Wang D; Cui S; Ren T; Cao Z; Liu Q; Chen Z; Chen X; Zhou Y
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3087-3094. PubMed ID: 28951211
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
Zhang ZC; Liu Y; Xiao LL; Li SF; Jiang JH; Zhao Y; Qian SW; Tang QQ; Li X
J Hepatol; 2015 Dec; 63(6):1466-75. PubMed ID: 26272872
[TBL] [Abstract][Full Text] [Related]
27. 6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade.
Ahn J; Lee H; Jung CH; Ha SY; Seo HD; Kim YI; Ha T
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1201-1213. PubMed ID: 34139323
[TBL] [Abstract][Full Text] [Related]
28. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
29. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway.
Yang W; Wang J; Chen Z; Chen J; Meng Y; Chen L; Chang Y; Geng B; Sun L; Dou L; Li J; Guan Y; Cui Q; Yang J
Diabetes; 2017 Jul; 66(7):1819-1832. PubMed ID: 28411267
[TBL] [Abstract][Full Text] [Related]
30. circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling.
Guo XY; Sun F; Chen JN; Wang YQ; Pan Q; Fan JG
World J Gastroenterol; 2018 Jan; 24(3):323-337. PubMed ID: 29391755
[TBL] [Abstract][Full Text] [Related]
31. Lycopene inhibits hepatic steatosis via microRNA-21-induced downregulation of fatty acid-binding protein 7 in mice fed a high-fat diet.
Ahn J; Lee H; Jung CH; Ha T
Mol Nutr Food Res; 2012 Nov; 56(11):1665-74. PubMed ID: 22968990
[TBL] [Abstract][Full Text] [Related]
32. Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients.
Ye D; Zhang T; Lou G; Xu W; Dong F; Chen G; Liu Y
Life Sci; 2018 Sep; 208():201-207. PubMed ID: 30030064
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-20a-5p contributes to hepatic glycogen synthesis through targeting p63 to regulate p53 and PTEN expression.
Fang W; Guo J; Cao Y; Wang S; Pang C; Li M; Dou L; Man Y; Huang X; Shen T; Li J
J Cell Mol Med; 2016 Aug; 20(8):1467-80. PubMed ID: 27019188
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-205 ameliorates lipid accumulation in non-alcoholic fatty liver disease through targeting NEU1.
Hu Y; Ye H; Shi LX
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10072-10082. PubMed ID: 31799678
[TBL] [Abstract][Full Text] [Related]
36. Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor.
Wang Z; Miu KK; Zhang X; Wan AT; Lu G; Cheung HH; Lee HM; Kong AP; Chan JC; Chan WY
JHEP Rep; 2020 Dec; 2(6):100179. PubMed ID: 33134908
[TBL] [Abstract][Full Text] [Related]
37. Deletion of Macrophage Mineralocorticoid Receptor Protects Hepatic Steatosis and Insulin Resistance Through ERα/HGF/Met Pathway.
Zhang YY; Li C; Yao GF; Du LJ; Liu Y; Zheng XJ; Yan S; Sun JY; Liu Y; Liu MZ; Zhang X; Wei G; Tong W; Chen X; Wu Y; Sun S; Liu S; Ding Q; Yu Y; Yin H; Duan SZ
Diabetes; 2017 Jun; 66(6):1535-1547. PubMed ID: 28325853
[TBL] [Abstract][Full Text] [Related]
38. Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via miR-5120/ABHD6.
Li R; Ye Z; She D; Fang P; Zong G; Hu K; Kong D; Xu W; Li L; Zhou Y; Zhang K; Xue Y
Drug Des Devel Ther; 2022; 16():3557-3572. PubMed ID: 36238196
[TBL] [Abstract][Full Text] [Related]
39. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease.
Huang R; Duan X; Liu X; Cao H; Wang Y; Fan J; Wang B
Biochem Biophys Res Commun; 2019 Jan; 508(4):1252-1258. PubMed ID: 30558790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]